Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox (Mpox) Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- The protein-only hypothesis
- Biochemical models of PrPres formation
- Outline
- PrPSc amplification in brain homogenates
- PrPSc amplification in brain homogenates: results
- Ribonuclease effect
- Production of purified prions in vitro
- Affinity purification of PrPC
- Affinity purification of PrPC: results
- Purified PrPSc propagation
- Purified PrPSc propagation: results
- Spontaneous PrPSc formation
- Bioassay of the prions produced in vitro
- Neuropathology
- Western blot of brain homogenates
- Physical interaction between PrP and polyanions
- Mechanism of polyanion interaction
- Nuclease protection assay
- Synthesis of radioactive probe
- Nuclease protection assay: results
- Post-translational modifications effects on PrPSc
- PrPC post-translational modifications
- Selectively glycosylated PrPC substrates (1)
- Selectively glycosylated PrPC substrates (2)
- PrP assembly in different animal species
- Assembly model and differences in amplification
- Inhibition of PrPSc amplification by metals
- Purified PrPSc amplification
- Effects of metals on PrPSc amplification
- Summary
- Acknowledgements
Topics Covered
- Prion propagation in vitro requires PrP plus an incorporated polyanion
- PrPC post-translational modifications influence prion formation
- Zinc and copper inhibit PrPSc amplification
- Update interview: Cofactor molecules and infectious mammalian prions in vitro
- Update interview: Cofactor molecules dictate the strain properties of infectious prions
- Update interview: PrPC post-translational modifications influence prion formation
- Update interview: Fully infectious prions can be made recombinant PrP substrate lacking post-translational modifications
- Update interview: Zinc and copper inhibit PrPSc amplification in vitro
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Supattapone, S. (2020, May 24). Mechanism of prion generation in vitro [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 21, 2024, from https://doi.org/10.69645/JTZY9206.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Surachai Supattapone has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Update Available
The speaker addresses developments since the publication of the original talk. We recommend listening to the associated update as well as the lecture.
- Full lecture Duration: 31:17 min
- Update Interview Duration: 8:23 min
A selection of talks on Neurology
Transcript
Please wait while the transcript is being prepared...
0:00
My name is Surachai Supattapone and
I'm from Dartmouth Medical School.
The subject of this talk will be the
mechanism of prion generation in vitro.
0:12
According to the protein-only hypothesis,
prion diseases are associated with
the conformational change of a normal
cellular protein known as the prion
protein (or PrPc) into an abnormal
disease-associated conformer
known as PrPScrapie (or PrPSc).
Whereas the normal PrPc
structure is non-infectious,
sensitive to protease digestion and
has a structure which has been
solved by NMR techniques, the PrPSc
isoform has an unknown structure and
is resistant to proteases,
which is a very useful property for
experimental detection of this isoform,
as will be shown in subsequent slides.
Furthermore, it is postulated
that PrPSc is in fact
the infectious entity of prion diseases.
This talk will primarily concern
recent discoveries that have been made
in studying the mechanism of
conformational change of PrPc to PrPSc in
in vitro systems.
1:16
There have been two important biochemical
models of PrPSc formation which
have been developed.
In 1994 Byron Caughey and his colleagues
at Rocky Mountain Laboratories
developed the cell-free conversion assay,
in which a radioactive
PrPc substrate was mixed together
with purified PrPSc template.
In this assay,
it was observed that the radioactive PrPc
substrate was converted into
a protease-resistant PrPSc
conformation in a species- and
strain-specific manner.
In the second assay, known as the 'protein
misfolding cyclic amplification'
(PMCA) assay developed by Claudio Soto and
his colleagues in 2001,
normal brain homogenates were mixed
with prion-infected brain homogenates,
and it was observed that the PrPc present
in the normal brain homogenate was
converted into the protease-resistant
PrPSc conformation.
Unlike the cell-free conversion assay,
small amounts
of PrPSc present in the infected
brain were able to cause
the autocatalytic transformation of
larger amounts of PrPc into PrPSc.
Furthermore, it could be shown that this
technique generates infectious prions.